10 research outputs found

    Correlation between Interleukin-6 and Thrombin–Antithrombin III Complex Levels in Retinal Diseases

    No full text
    <p><i>Purpose</i>: This study aims to evaluate and correlate the levels of interleukin-6 (IL-6) and thrombin–antithrombin III complex (TAT) in the vitreous of patients with different vitreoretinal pathologies.</p> <p><i>Methods</i>: Vitreous samples were collected from 78 patients scheduled for pars plana vitrectomy at a tertiary medical center. Patients were divided by the underlying vitreoretinal pathophysiology, as follows: macular hole (MH)/epiretinal membrane (ERM) (<i>n</i> = 26); rhegmatogenous retinal detachment (RRD) (<i>n</i> = 32); and proliferative diabetic retinopathy (PDR) (<i>n</i> = 20). Levels of IL-6 and TAT were measured by enzyme-linked immunosorbent assay and compared among the groups.</p> <p><i>Results</i>: A significant difference was found in the vitreal IL-6 and TAT levels between the MH/ERM group and both the PDR and RRD groups (<i>P</i> < 0.001 for all). Diabetes was associated with higher IL-6 levels in the RRD group. Different relationships between the IL-6 and TAT levels were revealed in patients with different ocular pathologies.</p> <p><i>Conclusion</i>: Our results imply that variations in vitreal TAT level may be attributable not only to an inflammatory reaction or blood–retinal barrier breakdown, but also to intraocular tissue-dependent regulation of thrombin.</p

    Functional Single-Chain Polymer Nanoparticles: Targeting and Imaging Pancreatic Tumors <i>in Vivo</i>

    No full text
    The development of tools for the early diagnosis of pancreatic adenocarcinoma is an urgent need in order to increase treatment success rate and reduce patient mortality. Here, we present a modular nanosystem platform integrating soft nanoparticles with a targeting peptide and an active imaging agent for diagnostics. Biocompatible single-chain polymer nanoparticles (SCPNs) based on poly­(methacrylic acid) were prepared and functionalized with the somatostatin analogue PTR86 as the targeting moiety, since somatostatin receptors are overexpressed in pancreatic cancer. The gamma emitter <sup>67</sup>Ga was incorporated by chelation and allowed <i>in vivo</i> investigation of the pharmacokinetic properties of the nanoparticles using single photon emission computerized tomography (SPECT). The resulting engineered nanosystem was tested in a xenograph mouse model of human pancreatic adenocarcinoma. Imaging results demonstrate that accumulation of targeted SCPNs in the tumor is higher than that observed for nontargeted nanoparticles due to improved retention in this tissue

    Abstracts of papers presented at the 15th conference of the weed science society of Israel

    No full text

    References

    No full text

    Abstracts of Presentations at the 21st congress of the Israeli phytopathological society February 14–15, 2000 ARO, the Volcani Center, Bet Dagan, Israel

    No full text
    corecore